References
- The tricontinental mycophenolate mofetil renal transplantation study group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation. 1996, 61(7), 1029–1037.
- Lee, W.A., Gu, L., Miksztal, A.R., Chu, N., Leung, K., Nelson, P.H.Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm. Res. 1990, 7, 161–166.
- Sugiyama, K., Satoh, H., Saito, K., Takahashi, K., Saito, N., Hirano, T.Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients. Transpl. Int. 2005, 18, 590–595.
- Sugiyama, K., Isogai, K., Toyama, A., Satoh, H., Saito, K., Nakagawa, Y., Tasaki, M., Takahashi, K., Saito, N., Hirano, T.Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantation. J. Clin. Pharm. Ther. 2009, 34, 539–545.
- Sugiyama, K., Arakawa, K., Satoh, H., Saito, K., Takahashi, K., Saito, N., Hirano, T.Correlation between pharmacological efficacy of cyclosporine A and tacrolimus, evaluated by lymphocyte immunosuppressant-sensitivity test (LIST) with MTT assay procedure in renal transplant recipients. J. Immunoassay Immunochem. 2006, 27, 195–205.
- Hirano, T., Oka, K., Takeuchi, H., Sakurai, E., Matsuno, N., Tamaki, T., Kozaki, M.Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. Transplantation. 1994, 57, 1341–1348.
- Rostaing, L., Puyoo, O., Tkaczuk, J., Peres, C., Rouzaud, A., Cisterne, J.M., de Preval, C., Ohayon, E., Durand, D., Abbal, M. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. Clin. Transplant. 1999, 13, 400–409.
- Grunewald, R.W., Fiedler, G.M., Stock, B., Grunewald, J.M., Müller, G.A.Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients. Nephrol. Dial. Transplant. 2000, 15, 71–77.
- Kyo, M., Toki, K., Nishimura, K., Fukunishi, T., Nagano, S., Namba, Y., Gudat, F., Dalquen, P., Mihatsch, M.J. Differential diagnosis of kidney transplant rejection and cyclosporin/tacrolimus nephropathy using urine cytology. Clin. Transplant. 2002, 16 Suppl 8, 40–44.